p27 expression and gastric carcinoma

被引:263
作者
Mori, M
Mimori, K
Shiraishi, T
Tanaka, S
Ueo, H
Sugimachi, K
Akiyoshi, T
机构
[1] OITA PREFECTURAL HOSP,DEPT SURG,OITA 875,JAPAN
[2] KYUSHU UNIV,FAC MED,DEPT SURG 2,FUKUOKA 812,JAPAN
关键词
D O I
10.1038/nm0697-593
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:593 / 593
页数:1
相关论文
共 4 条
[1]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[2]   Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas [J].
Loda, M ;
Cukor, B ;
Tam, SW ;
Lavin, P ;
Fiorentino, M ;
Draetta, GF ;
Jessup, JM ;
Pagano, M .
NATURE MEDICINE, 1997, 3 (02) :231-234
[3]   Expression of cell-cycle regulators p27(Kip1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients [J].
Porter, PL ;
Malone, KE ;
Heagerty, PJ ;
Alexander, GM ;
Gatti, LA ;
Firpo, EJ ;
Daling, JR ;
Roberts, JM .
NATURE MEDICINE, 1997, 3 (02) :222-225
[4]   Cancer prognostics: Past, present and p27 [J].
Steeg, PS ;
Abrams, JS .
NATURE MEDICINE, 1997, 3 (02) :152-154